nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—UGT1A1—Atorvastatin—hypertension	0.0509	0.0932	CbGbCtD
Naltrexone—UGT1A1—Losartan—hypertension	0.0465	0.0853	CbGbCtD
Naltrexone—ABCB1—Nadolol—hypertension	0.0273	0.05	CbGbCtD
Naltrexone—ABCB1—Acebutolol—hypertension	0.0249	0.0457	CbGbCtD
Naltrexone—ABCB1—Metoprolol—hypertension	0.0232	0.0425	CbGbCtD
Naltrexone—ABCB1—Candesartan—hypertension	0.0232	0.0425	CbGbCtD
Naltrexone—ABCB1—Terazosin—hypertension	0.0218	0.0399	CbGbCtD
Naltrexone—ABCB1—Reserpine—hypertension	0.0207	0.0379	CbGbCtD
Naltrexone—ABCB1—Perindopril—hypertension	0.0189	0.0346	CbGbCtD
Naltrexone—ABCB1—Doxazosin—hypertension	0.0182	0.0333	CbGbCtD
Naltrexone—ABCB1—Nisoldipine—hypertension	0.0182	0.0333	CbGbCtD
Naltrexone—ABCB1—Diltiazem—hypertension	0.0176	0.0322	CbGbCtD
Naltrexone—ABCB1—Telmisartan—hypertension	0.0165	0.0303	CbGbCtD
Naltrexone—ABCB1—Bepridil—hypertension	0.0157	0.0287	CbGbCtD
Naltrexone—ABCB1—Lisinopril—hypertension	0.0157	0.0287	CbGbCtD
Naltrexone—ABCB1—Enalapril—hypertension	0.0157	0.0287	CbGbCtD
Naltrexone—ABCB1—Prazosin—hypertension	0.0149	0.0274	CbGbCtD
Naltrexone—ABCB1—Amlodipine—hypertension	0.014	0.0257	CbGbCtD
Naltrexone—ABCB1—Spironolactone—hypertension	0.0138	0.0253	CbGbCtD
Naltrexone—ABCB1—Felodipine—hypertension	0.0135	0.0248	CbGbCtD
Naltrexone—ABCB1—Timolol—hypertension	0.0133	0.0244	CbGbCtD
Naltrexone—ABCB1—Nifedipine—hypertension	0.0131	0.024	CbGbCtD
Naltrexone—ABCB1—Nicardipine—hypertension	0.0129	0.0236	CbGbCtD
Naltrexone—ABCB1—Carvedilol—hypertension	0.0129	0.0236	CbGbCtD
Naltrexone—ABCB1—Propranolol—hypertension	0.0119	0.0217	CbGbCtD
Naltrexone—ABCB1—Captopril—hypertension	0.0117	0.0215	CbGbCtD
Naltrexone—ABCB1—Clonidine—hypertension	0.0113	0.0207	CbGbCtD
Naltrexone—ABCB1—Atorvastatin—hypertension	0.0101	0.0185	CbGbCtD
Naltrexone—ABCB1—Losartan—hypertension	0.00923	0.0169	CbGbCtD
Naltrexone—ABCB1—Verapamil—hypertension	0.00814	0.0149	CbGbCtD
Naltrexone—Buprenorphine—CYP2C18—hypertension	0.000583	0.322	CrCbGaD
Naltrexone—Oxycodone—CYP3A5—hypertension	0.000417	0.23	CrCbGaD
Naltrexone—Buprenorphine—CYP3A5—hypertension	0.000384	0.212	CrCbGaD
Naltrexone—Hydromorphone—PTGS1—hypertension	0.000281	0.155	CrCbGaD
Naltrexone—Naloxone—ALB—hypertension	0.000144	0.0796	CrCbGaD
Naltrexone—Headache—Eplerenone—hypertension	3.11e-05	9.91e-05	CcSEcCtD
Naltrexone—Rash—Nifedipine—hypertension	3.11e-05	9.9e-05	CcSEcCtD
Naltrexone—Nervous system disorder—Ramipril—hypertension	3.11e-05	9.89e-05	CcSEcCtD
Naltrexone—Dermatitis—Nifedipine—hypertension	3.1e-05	9.89e-05	CcSEcCtD
Naltrexone—Abdominal pain—Irbesartan—hypertension	3.1e-05	9.88e-05	CcSEcCtD
Naltrexone—Body temperature increased—Irbesartan—hypertension	3.1e-05	9.88e-05	CcSEcCtD
Naltrexone—Oedema—Timolol—hypertension	3.1e-05	9.86e-05	CcSEcCtD
Naltrexone—Anaphylactic shock—Timolol—hypertension	3.1e-05	9.86e-05	CcSEcCtD
Naltrexone—Loss of consciousness—Lisinopril—hypertension	3.09e-05	9.85e-05	CcSEcCtD
Naltrexone—Rash—Verapamil—hypertension	3.09e-05	9.85e-05	CcSEcCtD
Naltrexone—Urticaria—Hydrochlorothiazide—hypertension	3.09e-05	9.85e-05	CcSEcCtD
Naltrexone—Tachycardia—Ramipril—hypertension	3.09e-05	9.85e-05	CcSEcCtD
Naltrexone—Dermatitis—Verapamil—hypertension	3.09e-05	9.84e-05	CcSEcCtD
Naltrexone—Headache—Nifedipine—hypertension	3.09e-05	9.83e-05	CcSEcCtD
Naltrexone—Pruritus—Clonidine—hypertension	3.08e-05	9.81e-05	CcSEcCtD
Naltrexone—Abdominal pain—Hydrochlorothiazide—hypertension	3.08e-05	9.8e-05	CcSEcCtD
Naltrexone—Body temperature increased—Hydrochlorothiazide—hypertension	3.08e-05	9.8e-05	CcSEcCtD
Naltrexone—Skin disorder—Ramipril—hypertension	3.08e-05	9.8e-05	CcSEcCtD
Naltrexone—Infection—Timolol—hypertension	3.08e-05	9.8e-05	CcSEcCtD
Naltrexone—Headache—Verapamil—hypertension	3.07e-05	9.79e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Telmisartan—hypertension	3.07e-05	9.79e-05	CcSEcCtD
Naltrexone—Cough—Lisinopril—hypertension	3.07e-05	9.78e-05	CcSEcCtD
Naltrexone—Nausea—Diltiazem—hypertension	3.07e-05	9.77e-05	CcSEcCtD
Naltrexone—Nausea—Indapamide—hypertension	3.07e-05	9.77e-05	CcSEcCtD
Naltrexone—Hyperhidrosis—Ramipril—hypertension	3.06e-05	9.75e-05	CcSEcCtD
Naltrexone—Asthenia—Trandolapril—hypertension	3.05e-05	9.7e-05	CcSEcCtD
Naltrexone—Shock—Timolol—hypertension	3.05e-05	9.7e-05	CcSEcCtD
Naltrexone—Feeling abnormal—Losartan—hypertension	3.04e-05	9.7e-05	CcSEcCtD
Naltrexone—Urticaria—Furosemide—hypertension	3.04e-05	9.69e-05	CcSEcCtD
Naltrexone—Nervous system disorder—Timolol—hypertension	3.04e-05	9.67e-05	CcSEcCtD
Naltrexone—Nausea—Carvedilol—hypertension	3.04e-05	9.67e-05	CcSEcCtD
Naltrexone—Asthenia—Enalapril—hypertension	3.03e-05	9.67e-05	CcSEcCtD
Naltrexone—Abdominal pain—Furosemide—hypertension	3.03e-05	9.64e-05	CcSEcCtD
Naltrexone—Body temperature increased—Furosemide—hypertension	3.03e-05	9.64e-05	CcSEcCtD
Naltrexone—Gastrointestinal pain—Losartan—hypertension	3.02e-05	9.62e-05	CcSEcCtD
Naltrexone—Dizziness—Valsartan—hypertension	3.02e-05	9.62e-05	CcSEcCtD
Naltrexone—Anorexia—Ramipril—hypertension	3.02e-05	9.62e-05	CcSEcCtD
Naltrexone—Urticaria—Betaxolol—hypertension	3.01e-05	9.59e-05	CcSEcCtD
Naltrexone—Skin disorder—Timolol—hypertension	3.01e-05	9.58e-05	CcSEcCtD
Naltrexone—Dizziness—Olmesartan—hypertension	3.01e-05	9.57e-05	CcSEcCtD
Naltrexone—Pruritus—Trandolapril—hypertension	3e-05	9.57e-05	CcSEcCtD
Naltrexone—Nausea—Doxazosin—hypertension	3e-05	9.57e-05	CcSEcCtD
Naltrexone—Arthralgia—Lisinopril—hypertension	3e-05	9.55e-05	CcSEcCtD
Naltrexone—Chest pain—Lisinopril—hypertension	3e-05	9.55e-05	CcSEcCtD
Naltrexone—Myalgia—Lisinopril—hypertension	3e-05	9.55e-05	CcSEcCtD
Naltrexone—Body temperature increased—Betaxolol—hypertension	3e-05	9.54e-05	CcSEcCtD
Naltrexone—Hyperhidrosis—Timolol—hypertension	2.99e-05	9.54e-05	CcSEcCtD
Naltrexone—Asthenia—Telmisartan—hypertension	2.99e-05	9.53e-05	CcSEcCtD
Naltrexone—Pruritus—Enalapril—hypertension	2.99e-05	9.53e-05	CcSEcCtD
Naltrexone—Anxiety—Lisinopril—hypertension	2.99e-05	9.51e-05	CcSEcCtD
Naltrexone—Diarrhoea—Clonidine—hypertension	2.98e-05	9.49e-05	CcSEcCtD
Naltrexone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	2.98e-05	9.48e-05	CcSEcCtD
Naltrexone—Nausea—Fosinopril—hypertension	2.97e-05	9.45e-05	CcSEcCtD
Naltrexone—Discomfort—Lisinopril—hypertension	2.96e-05	9.43e-05	CcSEcCtD
Naltrexone—Anorexia—Timolol—hypertension	2.95e-05	9.4e-05	CcSEcCtD
Naltrexone—Pruritus—Telmisartan—hypertension	2.95e-05	9.4e-05	CcSEcCtD
Naltrexone—Nausea—Eplerenone—hypertension	2.95e-05	9.39e-05	CcSEcCtD
Naltrexone—Urticaria—Losartan—hypertension	2.93e-05	9.35e-05	CcSEcCtD
Naltrexone—Dry mouth—Lisinopril—hypertension	2.93e-05	9.34e-05	CcSEcCtD
Naltrexone—Nausea—Nifedipine—hypertension	2.93e-05	9.32e-05	CcSEcCtD
Naltrexone—Abdominal pain—Losartan—hypertension	2.92e-05	9.3e-05	CcSEcCtD
Naltrexone—Body temperature increased—Losartan—hypertension	2.92e-05	9.3e-05	CcSEcCtD
Naltrexone—Nausea—Verapamil—hypertension	2.91e-05	9.28e-05	CcSEcCtD
Naltrexone—Asthenia—Captopril—hypertension	2.91e-05	9.27e-05	CcSEcCtD
Naltrexone—Diarrhoea—Trandolapril—hypertension	2.9e-05	9.25e-05	CcSEcCtD
Naltrexone—Vomiting—Valsartan—hypertension	2.9e-05	9.25e-05	CcSEcCtD
Naltrexone—Confusional state—Lisinopril—hypertension	2.9e-05	9.23e-05	CcSEcCtD
Naltrexone—Diarrhoea—Enalapril—hypertension	2.89e-05	9.22e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Irbesartan—hypertension	2.89e-05	9.21e-05	CcSEcCtD
Naltrexone—Vomiting—Olmesartan—hypertension	2.89e-05	9.21e-05	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Ramipril—hypertension	2.89e-05	9.19e-05	CcSEcCtD
Naltrexone—Rash—Valsartan—hypertension	2.88e-05	9.17e-05	CcSEcCtD
Naltrexone—Dizziness—Clonidine—hypertension	2.88e-05	9.17e-05	CcSEcCtD
Naltrexone—Dermatitis—Valsartan—hypertension	2.88e-05	9.17e-05	CcSEcCtD
Naltrexone—Anaphylactic shock—Lisinopril—hypertension	2.87e-05	9.15e-05	CcSEcCtD
Naltrexone—Oedema—Lisinopril—hypertension	2.87e-05	9.15e-05	CcSEcCtD
Naltrexone—Pruritus—Captopril—hypertension	2.87e-05	9.14e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Hydrochlorothiazide—hypertension	2.87e-05	9.14e-05	CcSEcCtD
Naltrexone—Rash—Olmesartan—hypertension	2.87e-05	9.13e-05	CcSEcCtD
Naltrexone—Insomnia—Ramipril—hypertension	2.86e-05	9.13e-05	CcSEcCtD
Naltrexone—Dermatitis—Olmesartan—hypertension	2.86e-05	9.12e-05	CcSEcCtD
Naltrexone—Headache—Valsartan—hypertension	2.86e-05	9.11e-05	CcSEcCtD
Naltrexone—Diarrhoea—Telmisartan—hypertension	2.85e-05	9.09e-05	CcSEcCtD
Naltrexone—Infection—Lisinopril—hypertension	2.85e-05	9.09e-05	CcSEcCtD
Naltrexone—Headache—Olmesartan—hypertension	2.85e-05	9.07e-05	CcSEcCtD
Naltrexone—Paraesthesia—Ramipril—hypertension	2.84e-05	9.06e-05	CcSEcCtD
Naltrexone—Shock—Lisinopril—hypertension	2.83e-05	9e-05	CcSEcCtD
Naltrexone—Asthenia—Perindopril—hypertension	2.83e-05	9e-05	CcSEcCtD
Naltrexone—Dyspnoea—Ramipril—hypertension	2.82e-05	9e-05	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Timolol—hypertension	2.82e-05	8.99e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Furosemide—hypertension	2.82e-05	8.99e-05	CcSEcCtD
Naltrexone—Asthenia—Irbesartan—hypertension	2.82e-05	8.97e-05	CcSEcCtD
Naltrexone—Somnolence—Ramipril—hypertension	2.82e-05	8.97e-05	CcSEcCtD
Naltrexone—Dizziness—Trandolapril—hypertension	2.81e-05	8.94e-05	CcSEcCtD
Naltrexone—Tachycardia—Lisinopril—hypertension	2.8e-05	8.93e-05	CcSEcCtD
Naltrexone—Insomnia—Timolol—hypertension	2.8e-05	8.92e-05	CcSEcCtD
Naltrexone—Dizziness—Enalapril—hypertension	2.8e-05	8.91e-05	CcSEcCtD
Naltrexone—Asthenia—Hydrochlorothiazide—hypertension	2.79e-05	8.9e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Betaxolol—hypertension	2.79e-05	8.9e-05	CcSEcCtD
Naltrexone—Skin disorder—Lisinopril—hypertension	2.79e-05	8.89e-05	CcSEcCtD
Naltrexone—Pruritus—Perindopril—hypertension	2.79e-05	8.88e-05	CcSEcCtD
Naltrexone—Paraesthesia—Timolol—hypertension	2.78e-05	8.86e-05	CcSEcCtD
Naltrexone—Pruritus—Irbesartan—hypertension	2.78e-05	8.85e-05	CcSEcCtD
Naltrexone—Hyperhidrosis—Lisinopril—hypertension	2.78e-05	8.85e-05	CcSEcCtD
Naltrexone—Diarrhoea—Captopril—hypertension	2.77e-05	8.84e-05	CcSEcCtD
Naltrexone—Vomiting—Clonidine—hypertension	2.77e-05	8.82e-05	CcSEcCtD
Naltrexone—Dyspnoea—Timolol—hypertension	2.76e-05	8.79e-05	CcSEcCtD
Naltrexone—Dizziness—Telmisartan—hypertension	2.76e-05	8.79e-05	CcSEcCtD
Naltrexone—Pruritus—Hydrochlorothiazide—hypertension	2.75e-05	8.77e-05	CcSEcCtD
Naltrexone—Decreased appetite—Ramipril—hypertension	2.75e-05	8.77e-05	CcSEcCtD
Naltrexone—Somnolence—Timolol—hypertension	2.75e-05	8.77e-05	CcSEcCtD
Naltrexone—Asthenia—Furosemide—hypertension	2.75e-05	8.75e-05	CcSEcCtD
Naltrexone—Rash—Clonidine—hypertension	2.74e-05	8.74e-05	CcSEcCtD
Naltrexone—Dermatitis—Clonidine—hypertension	2.74e-05	8.74e-05	CcSEcCtD
Naltrexone—Anorexia—Lisinopril—hypertension	2.74e-05	8.72e-05	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Ramipril—hypertension	2.73e-05	8.71e-05	CcSEcCtD
Naltrexone—Fatigue—Ramipril—hypertension	2.73e-05	8.7e-05	CcSEcCtD
Naltrexone—Headache—Clonidine—hypertension	2.73e-05	8.69e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Losartan—hypertension	2.72e-05	8.67e-05	CcSEcCtD
Naltrexone—Asthenia—Betaxolol—hypertension	2.72e-05	8.66e-05	CcSEcCtD
Naltrexone—Nausea—Valsartan—hypertension	2.71e-05	8.64e-05	CcSEcCtD
Naltrexone—Pruritus—Furosemide—hypertension	2.71e-05	8.63e-05	CcSEcCtD
Naltrexone—Constipation—Ramipril—hypertension	2.71e-05	8.63e-05	CcSEcCtD
Naltrexone—Nausea—Olmesartan—hypertension	2.7e-05	8.6e-05	CcSEcCtD
Naltrexone—Vomiting—Trandolapril—hypertension	2.7e-05	8.6e-05	CcSEcCtD
Naltrexone—Diarrhoea—Perindopril—hypertension	2.69e-05	8.58e-05	CcSEcCtD
Naltrexone—Decreased appetite—Timolol—hypertension	2.69e-05	8.57e-05	CcSEcCtD
Naltrexone—Vomiting—Enalapril—hypertension	2.69e-05	8.57e-05	CcSEcCtD
Naltrexone—Diarrhoea—Irbesartan—hypertension	2.69e-05	8.55e-05	CcSEcCtD
Naltrexone—Dizziness—Captopril—hypertension	2.68e-05	8.54e-05	CcSEcCtD
Naltrexone—Pruritus—Betaxolol—hypertension	2.68e-05	8.54e-05	CcSEcCtD
Naltrexone—Rash—Trandolapril—hypertension	2.68e-05	8.53e-05	CcSEcCtD
Naltrexone—Dermatitis—Trandolapril—hypertension	2.67e-05	8.52e-05	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Timolol—hypertension	2.67e-05	8.52e-05	CcSEcCtD
Naltrexone—Fatigue—Timolol—hypertension	2.67e-05	8.5e-05	CcSEcCtD
Naltrexone—Rash—Enalapril—hypertension	2.67e-05	8.49e-05	CcSEcCtD
Naltrexone—Dermatitis—Enalapril—hypertension	2.66e-05	8.49e-05	CcSEcCtD
Naltrexone—Diarrhoea—Hydrochlorothiazide—hypertension	2.66e-05	8.48e-05	CcSEcCtD
Naltrexone—Headache—Trandolapril—hypertension	2.66e-05	8.47e-05	CcSEcCtD
Naltrexone—Vomiting—Telmisartan—hypertension	2.65e-05	8.45e-05	CcSEcCtD
Naltrexone—Asthenia—Losartan—hypertension	2.65e-05	8.44e-05	CcSEcCtD
Naltrexone—Headache—Enalapril—hypertension	2.65e-05	8.44e-05	CcSEcCtD
Naltrexone—Pain—Timolol—hypertension	2.65e-05	8.43e-05	CcSEcCtD
Naltrexone—Rash—Telmisartan—hypertension	2.63e-05	8.38e-05	CcSEcCtD
Naltrexone—Dermatitis—Telmisartan—hypertension	2.63e-05	8.37e-05	CcSEcCtD
Naltrexone—Diarrhoea—Furosemide—hypertension	2.62e-05	8.34e-05	CcSEcCtD
Naltrexone—Musculoskeletal discomfort—Lisinopril—hypertension	2.62e-05	8.34e-05	CcSEcCtD
Naltrexone—Pruritus—Losartan—hypertension	2.61e-05	8.33e-05	CcSEcCtD
Naltrexone—Headache—Telmisartan—hypertension	2.61e-05	8.32e-05	CcSEcCtD
Naltrexone—Feeling abnormal—Ramipril—hypertension	2.61e-05	8.31e-05	CcSEcCtD
Naltrexone—Dizziness—Perindopril—hypertension	2.6e-05	8.3e-05	CcSEcCtD
Naltrexone—Insomnia—Lisinopril—hypertension	2.6e-05	8.28e-05	CcSEcCtD
Naltrexone—Dizziness—Irbesartan—hypertension	2.6e-05	8.27e-05	CcSEcCtD
Naltrexone—Diarrhoea—Betaxolol—hypertension	2.59e-05	8.26e-05	CcSEcCtD
Naltrexone—Gastrointestinal pain—Ramipril—hypertension	2.59e-05	8.25e-05	CcSEcCtD
Naltrexone—Nausea—Clonidine—hypertension	2.59e-05	8.24e-05	CcSEcCtD
Naltrexone—Paraesthesia—Lisinopril—hypertension	2.58e-05	8.22e-05	CcSEcCtD
Naltrexone—Vomiting—Captopril—hypertension	2.58e-05	8.22e-05	CcSEcCtD
Naltrexone—Dizziness—Hydrochlorothiazide—hypertension	2.57e-05	8.2e-05	CcSEcCtD
Naltrexone—Dyspnoea—Lisinopril—hypertension	2.56e-05	8.16e-05	CcSEcCtD
Naltrexone—Rash—Captopril—hypertension	2.56e-05	8.15e-05	CcSEcCtD
Naltrexone—Dermatitis—Captopril—hypertension	2.55e-05	8.14e-05	CcSEcCtD
Naltrexone—Somnolence—Lisinopril—hypertension	2.55e-05	8.13e-05	CcSEcCtD
Naltrexone—Feeling abnormal—Timolol—hypertension	2.55e-05	8.13e-05	CcSEcCtD
Naltrexone—Headache—Captopril—hypertension	2.54e-05	8.09e-05	CcSEcCtD
Naltrexone—Gastrointestinal pain—Timolol—hypertension	2.53e-05	8.07e-05	CcSEcCtD
Naltrexone—Dizziness—Furosemide—hypertension	2.53e-05	8.06e-05	CcSEcCtD
Naltrexone—Diarrhoea—Losartan—hypertension	2.53e-05	8.05e-05	CcSEcCtD
Naltrexone—Nausea—Trandolapril—hypertension	2.52e-05	8.03e-05	CcSEcCtD
Naltrexone—Urticaria—Ramipril—hypertension	2.52e-05	8.02e-05	CcSEcCtD
Naltrexone—Nausea—Enalapril—hypertension	2.51e-05	8e-05	CcSEcCtD
Naltrexone—Dizziness—Betaxolol—hypertension	2.51e-05	7.98e-05	CcSEcCtD
Naltrexone—Vomiting—Perindopril—hypertension	2.5e-05	7.98e-05	CcSEcCtD
Naltrexone—Body temperature increased—Ramipril—hypertension	2.5e-05	7.98e-05	CcSEcCtD
Naltrexone—Abdominal pain—Ramipril—hypertension	2.5e-05	7.98e-05	CcSEcCtD
Naltrexone—Decreased appetite—Lisinopril—hypertension	2.5e-05	7.95e-05	CcSEcCtD
Naltrexone—Vomiting—Irbesartan—hypertension	2.5e-05	7.95e-05	CcSEcCtD
Naltrexone—Rash—Perindopril—hypertension	2.48e-05	7.91e-05	CcSEcCtD
Naltrexone—Dermatitis—Perindopril—hypertension	2.48e-05	7.9e-05	CcSEcCtD
Naltrexone—Gastrointestinal disorder—Lisinopril—hypertension	2.48e-05	7.9e-05	CcSEcCtD
Naltrexone—Nausea—Telmisartan—hypertension	2.48e-05	7.89e-05	CcSEcCtD
Naltrexone—Fatigue—Lisinopril—hypertension	2.48e-05	7.89e-05	CcSEcCtD
Naltrexone—Vomiting—Hydrochlorothiazide—hypertension	2.47e-05	7.88e-05	CcSEcCtD
Naltrexone—Rash—Irbesartan—hypertension	2.47e-05	7.88e-05	CcSEcCtD
Naltrexone—Dermatitis—Irbesartan—hypertension	2.47e-05	7.88e-05	CcSEcCtD
Naltrexone—Headache—Perindopril—hypertension	2.47e-05	7.86e-05	CcSEcCtD
Naltrexone—Urticaria—Timolol—hypertension	2.46e-05	7.84e-05	CcSEcCtD
Naltrexone—Headache—Irbesartan—hypertension	2.46e-05	7.83e-05	CcSEcCtD
Naltrexone—Pain—Lisinopril—hypertension	2.46e-05	7.82e-05	CcSEcCtD
Naltrexone—Constipation—Lisinopril—hypertension	2.46e-05	7.82e-05	CcSEcCtD
Naltrexone—Rash—Hydrochlorothiazide—hypertension	2.45e-05	7.82e-05	CcSEcCtD
Naltrexone—Dermatitis—Hydrochlorothiazide—hypertension	2.45e-05	7.81e-05	CcSEcCtD
Naltrexone—Abdominal pain—Timolol—hypertension	2.45e-05	7.8e-05	CcSEcCtD
Naltrexone—Body temperature increased—Timolol—hypertension	2.45e-05	7.8e-05	CcSEcCtD
Naltrexone—Dizziness—Losartan—hypertension	2.44e-05	7.78e-05	CcSEcCtD
Naltrexone—Headache—Hydrochlorothiazide—hypertension	2.44e-05	7.77e-05	CcSEcCtD
Naltrexone—Vomiting—Furosemide—hypertension	2.43e-05	7.75e-05	CcSEcCtD
Naltrexone—Rash—Furosemide—hypertension	2.41e-05	7.69e-05	CcSEcCtD
Naltrexone—Dermatitis—Furosemide—hypertension	2.41e-05	7.68e-05	CcSEcCtD
Naltrexone—Vomiting—Betaxolol—hypertension	2.41e-05	7.68e-05	CcSEcCtD
Naltrexone—Nausea—Captopril—hypertension	2.41e-05	7.67e-05	CcSEcCtD
Naltrexone—Headache—Furosemide—hypertension	2.4e-05	7.64e-05	CcSEcCtD
Naltrexone—Rash—Betaxolol—hypertension	2.39e-05	7.61e-05	CcSEcCtD
Naltrexone—Dermatitis—Betaxolol—hypertension	2.39e-05	7.61e-05	CcSEcCtD
Naltrexone—Headache—Betaxolol—hypertension	2.37e-05	7.56e-05	CcSEcCtD
Naltrexone—Feeling abnormal—Lisinopril—hypertension	2.37e-05	7.54e-05	CcSEcCtD
Naltrexone—Gastrointestinal pain—Lisinopril—hypertension	2.35e-05	7.48e-05	CcSEcCtD
Naltrexone—Vomiting—Losartan—hypertension	2.35e-05	7.48e-05	CcSEcCtD
Naltrexone—Nausea—Perindopril—hypertension	2.34e-05	7.45e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Ramipril—hypertension	2.33e-05	7.43e-05	CcSEcCtD
Naltrexone—Nausea—Irbesartan—hypertension	2.33e-05	7.43e-05	CcSEcCtD
Naltrexone—Rash—Losartan—hypertension	2.33e-05	7.42e-05	CcSEcCtD
Naltrexone—Dermatitis—Losartan—hypertension	2.33e-05	7.41e-05	CcSEcCtD
Naltrexone—Headache—Losartan—hypertension	2.31e-05	7.37e-05	CcSEcCtD
Naltrexone—Nausea—Hydrochlorothiazide—hypertension	2.31e-05	7.37e-05	CcSEcCtD
Naltrexone—Urticaria—Lisinopril—hypertension	2.28e-05	7.27e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Timolol—hypertension	2.28e-05	7.27e-05	CcSEcCtD
Naltrexone—Nausea—Furosemide—hypertension	2.27e-05	7.24e-05	CcSEcCtD
Naltrexone—Asthenia—Ramipril—hypertension	2.27e-05	7.24e-05	CcSEcCtD
Naltrexone—Body temperature increased—Lisinopril—hypertension	2.27e-05	7.23e-05	CcSEcCtD
Naltrexone—Abdominal pain—Lisinopril—hypertension	2.27e-05	7.23e-05	CcSEcCtD
Naltrexone—Nausea—Betaxolol—hypertension	2.25e-05	7.17e-05	CcSEcCtD
Naltrexone—Pruritus—Ramipril—hypertension	2.24e-05	7.14e-05	CcSEcCtD
Naltrexone—Asthenia—Timolol—hypertension	2.22e-05	7.08e-05	CcSEcCtD
Naltrexone—Nausea—Losartan—hypertension	2.19e-05	6.99e-05	CcSEcCtD
Naltrexone—Pruritus—Timolol—hypertension	2.19e-05	6.98e-05	CcSEcCtD
Naltrexone—Diarrhoea—Ramipril—hypertension	2.17e-05	6.9e-05	CcSEcCtD
Naltrexone—Diarrhoea—Timolol—hypertension	2.12e-05	6.75e-05	CcSEcCtD
Naltrexone—Hypersensitivity—Lisinopril—hypertension	2.12e-05	6.74e-05	CcSEcCtD
Naltrexone—Dizziness—Ramipril—hypertension	2.09e-05	6.67e-05	CcSEcCtD
Naltrexone—Asthenia—Lisinopril—hypertension	2.06e-05	6.57e-05	CcSEcCtD
Naltrexone—Dizziness—Timolol—hypertension	2.05e-05	6.52e-05	CcSEcCtD
Naltrexone—Pruritus—Lisinopril—hypertension	2.03e-05	6.47e-05	CcSEcCtD
Naltrexone—Vomiting—Ramipril—hypertension	2.01e-05	6.42e-05	CcSEcCtD
Naltrexone—Rash—Ramipril—hypertension	2e-05	6.36e-05	CcSEcCtD
Naltrexone—Dermatitis—Ramipril—hypertension	2e-05	6.36e-05	CcSEcCtD
Naltrexone—Headache—Ramipril—hypertension	1.98e-05	6.32e-05	CcSEcCtD
Naltrexone—Vomiting—Timolol—hypertension	1.97e-05	6.27e-05	CcSEcCtD
Naltrexone—Diarrhoea—Lisinopril—hypertension	1.97e-05	6.26e-05	CcSEcCtD
Naltrexone—Rash—Timolol—hypertension	1.95e-05	6.22e-05	CcSEcCtD
Naltrexone—Dermatitis—Timolol—hypertension	1.95e-05	6.21e-05	CcSEcCtD
Naltrexone—Headache—Timolol—hypertension	1.94e-05	6.18e-05	CcSEcCtD
Naltrexone—Dizziness—Lisinopril—hypertension	1.9e-05	6.05e-05	CcSEcCtD
Naltrexone—Nausea—Ramipril—hypertension	1.88e-05	5.99e-05	CcSEcCtD
Naltrexone—Nausea—Timolol—hypertension	1.84e-05	5.86e-05	CcSEcCtD
Naltrexone—Vomiting—Lisinopril—hypertension	1.83e-05	5.82e-05	CcSEcCtD
Naltrexone—Rash—Lisinopril—hypertension	1.81e-05	5.77e-05	CcSEcCtD
Naltrexone—Dermatitis—Lisinopril—hypertension	1.81e-05	5.76e-05	CcSEcCtD
Naltrexone—Headache—Lisinopril—hypertension	1.8e-05	5.73e-05	CcSEcCtD
Naltrexone—Nausea—Lisinopril—hypertension	1.71e-05	5.44e-05	CcSEcCtD
Naltrexone—OPRD1—Signaling Pathways—AGT—hypertension	9.03e-06	6.51e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADRB2—hypertension	9.03e-06	6.51e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCG—hypertension	9e-06	6.49e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ITGB3—hypertension	8.94e-06	6.45e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCA—hypertension	8.94e-06	6.45e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCE—hypertension	8.91e-06	6.43e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CALM1—hypertension	8.88e-06	6.41e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—YWHAZ—hypertension	8.87e-06	6.4e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—APOE—hypertension	8.85e-06	6.38e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—LEP—hypertension	8.85e-06	6.38e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VAV3—hypertension	8.8e-06	6.35e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDGFA—hypertension	8.8e-06	6.35e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NGF—hypertension	8.77e-06	6.32e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SPP1—hypertension	8.77e-06	6.32e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CAV1—hypertension	8.77e-06	6.32e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—APOA1—hypertension	8.75e-06	6.31e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CXCL8—hypertension	8.73e-06	6.3e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP2C18—hypertension	8.68e-06	6.26e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—LRP2—hypertension	8.68e-06	6.26e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFBR2—hypertension	8.68e-06	6.26e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—KDR—hypertension	8.67e-06	6.25e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MTHFR—hypertension	8.62e-06	6.21e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GNB3—hypertension	8.6e-06	6.2e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCR5—hypertension	8.53e-06	6.15e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCD—hypertension	8.53e-06	6.15e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AVP—hypertension	8.48e-06	6.11e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PPARA—hypertension	8.45e-06	6.1e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—RHOA—hypertension	8.41e-06	6.06e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—GNAS—hypertension	8.37e-06	6.04e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HSPG2—hypertension	8.36e-06	6.03e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—hypertension	8.35e-06	6.02e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—F2—hypertension	8.35e-06	6.02e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PRKCB—hypertension	8.35e-06	6.02e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FN1—hypertension	8.35e-06	6.02e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—C3—hypertension	8.34e-06	6.01e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—PIK3R1—hypertension	8.32e-06	6e-05	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—PPARA—hypertension	8.28e-06	5.97e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APOB—hypertension	8.2e-06	5.91e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—AGT—hypertension	8.19e-06	5.9e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NOTCH1—hypertension	8.17e-06	5.89e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTK2—hypertension	8.16e-06	5.89e-05	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CXCL8—hypertension	8.13e-06	5.86e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PDGFB—hypertension	8.11e-06	5.85e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGFR1—hypertension	8.07e-06	5.82e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALOX5—hypertension	8.07e-06	5.82e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GLP1R—hypertension	8.07e-06	5.82e-05	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hypertension	8.07e-06	5.82e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EDN1—hypertension	8.07e-06	5.82e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CALM1—hypertension	8.05e-06	5.81e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—APOE—hypertension	8.02e-06	5.79e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL5—hypertension	8e-06	5.77e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HIF1A—hypertension	7.95e-06	5.73e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CAV1—hypertension	7.95e-06	5.73e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—APOA1—hypertension	7.93e-06	5.72e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AGT—hypertension	7.92e-06	5.71e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LPL—hypertension	7.83e-06	5.64e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CALM1—hypertension	7.79e-06	5.62e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—H2AFX—hypertension	7.77e-06	5.6e-05	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—APOA1—hypertension	7.77e-06	5.6e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—LEP—hypertension	7.76e-06	5.6e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—APOE—hypertension	7.76e-06	5.6e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RPS6KB1—hypertension	7.76e-06	5.59e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDGFRB—hypertension	7.76e-06	5.59e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CAV1—hypertension	7.69e-06	5.55e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—APOA1—hypertension	7.67e-06	5.53e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADCY5—hypertension	7.66e-06	5.52e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCG—hypertension	7.61e-06	5.49e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—hypertension	7.6e-06	5.48e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—KDR—hypertension	7.6e-06	5.48e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—INS—hypertension	7.56e-06	5.45e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCA—hypertension	7.56e-06	5.45e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ITGB3—hypertension	7.56e-06	5.45e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—YWHAZ—hypertension	7.5e-06	5.41e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CCL2—hypertension	7.44e-06	5.37e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SPP1—hypertension	7.41e-06	5.34e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NGF—hypertension	7.41e-06	5.34e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALDH2—hypertension	7.38e-06	5.32e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CXCL8—hypertension	7.38e-06	5.32e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PRKCB—hypertension	7.32e-06	5.28e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—F2—hypertension	7.32e-06	5.28e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FN1—hypertension	7.32e-06	5.28e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IGF1—hypertension	7.31e-06	5.27e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—AKT2—hypertension	7.31e-06	5.27e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—EGFR—hypertension	7.28e-06	5.25e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCR5—hypertension	7.21e-06	5.2e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCD—hypertension	7.21e-06	5.2e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HBA1—hypertension	7.19e-06	5.19e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NOTCH1—hypertension	7.16e-06	5.17e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP11A1—hypertension	7.15e-06	5.16e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—hypertension	7.06e-06	5.09e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—C3—hypertension	7.05e-06	5.08e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC9A1—hypertension	7.02e-06	5.06e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTT1—hypertension	7.02e-06	5.06e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PPARG—hypertension	6.99e-06	5.04e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SERPINE1—hypertension	6.95e-06	5.01e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CETP—hypertension	6.94e-06	5.01e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GCLC—hypertension	6.94e-06	5.01e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—hypertension	6.89e-06	4.97e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PDGFB—hypertension	6.86e-06	4.95e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—INS—hypertension	6.85e-06	4.94e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGFR1—hypertension	6.82e-06	4.92e-05	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hypertension	6.81e-06	4.91e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—FGF2—hypertension	6.72e-06	4.85e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HIF1A—hypertension	6.72e-06	4.85e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RHOA—hypertension	6.7e-06	4.83e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AGT—hypertension	6.69e-06	4.83e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—hypertension	6.67e-06	4.81e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP17A1—hypertension	6.65e-06	4.79e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PIK3R1—hypertension	6.63e-06	4.78e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—NOS3—hypertension	6.63e-06	4.78e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—INS—hypertension	6.63e-06	4.78e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CALM1—hypertension	6.58e-06	4.75e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ENO1—hypertension	6.58e-06	4.75e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS1—hypertension	6.58e-06	4.75e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—LEP—hypertension	6.56e-06	4.73e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APOE—hypertension	6.56e-06	4.73e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CCL2—hypertension	6.52e-06	4.7e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CAV1—hypertension	6.5e-06	4.69e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—APOA1—hypertension	6.48e-06	4.68e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—KDR—hypertension	6.43e-06	4.63e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IGF1—hypertension	6.41e-06	4.62e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AKT2—hypertension	6.41e-06	4.62e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—EGFR—hypertension	6.38e-06	4.6e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CTGF—hypertension	6.33e-06	4.57e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—ALB—hypertension	6.28e-06	4.53e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GOT2—hypertension	6.28e-06	4.53e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HMGCR—hypertension	6.28e-06	4.53e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—RELA—hypertension	6.24e-06	4.5e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—F2—hypertension	6.19e-06	4.46e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PRKCB—hypertension	6.19e-06	4.46e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FN1—hypertension	6.19e-06	4.46e-05	CbGpPWpGaD
Naltrexone—ABCB1—Transmembrane transport of small molecules—ALB—hypertension	6.15e-06	4.44e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADRA2A—hypertension	6.14e-06	4.43e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MTOR—hypertension	6.12e-06	4.41e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SERPINE1—hypertension	6.09e-06	4.39e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NOTCH1—hypertension	6.05e-06	4.37e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PIK3R1—hypertension	6.01e-06	4.33e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—NOS3—hypertension	6.01e-06	4.33e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—FGF2—hypertension	5.9e-06	4.25e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CXCL8—hypertension	5.88e-06	4.24e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RHOA—hypertension	5.88e-06	4.24e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—NOS3—hypertension	5.81e-06	4.19e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PIK3R1—hypertension	5.81e-06	4.19e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TH—hypertension	5.75e-06	4.15e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CALM2—hypertension	5.73e-06	4.13e-05	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—AKT1—hypertension	5.68e-06	4.1e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—hypertension	5.64e-06	4.06e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—INS—hypertension	5.6e-06	4.04e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GCG—hypertension	5.6e-06	4.03e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—SLC2A4—hypertension	5.6e-06	4.03e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—IL6—hypertension	5.59e-06	4.03e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CCL2—hypertension	5.51e-06	3.98e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTGS2—hypertension	5.5e-06	3.96e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—RELA—hypertension	5.47e-06	3.95e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IGF1—hypertension	5.42e-06	3.91e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GOT1—hypertension	5.42e-06	3.91e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AKT2—hypertension	5.42e-06	3.91e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—EGFR—hypertension	5.39e-06	3.89e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MTOR—hypertension	5.37e-06	3.87e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MMP9—hypertension	5.32e-06	3.84e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CDKN1A—hypertension	5.3e-06	3.82e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—PTEN—hypertension	5.29e-06	3.81e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—STK11—hypertension	5.26e-06	3.79e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP19A1—hypertension	5.26e-06	3.79e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MAPK8—hypertension	5.17e-06	3.73e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—AKT1—hypertension	5.16e-06	3.72e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CXCL8—hypertension	5.16e-06	3.72e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SERPINE1—hypertension	5.15e-06	3.71e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EP300—hypertension	5.04e-06	3.64e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—FGF2—hypertension	4.98e-06	3.59e-05	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—AKT1—hypertension	4.98e-06	3.59e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RHOA—hypertension	4.97e-06	3.58e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—NOS3—hypertension	4.91e-06	3.54e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PIK3R1—hypertension	4.91e-06	3.54e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—SRC—hypertension	4.91e-06	3.54e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—IL6—hypertension	4.9e-06	3.54e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—COMT—hypertension	4.89e-06	3.53e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GNB3—hypertension	4.82e-06	3.48e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPARGC1A—hypertension	4.82e-06	3.48e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—HMOX1—hypertension	4.8e-06	3.46e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—PTEN—hypertension	4.79e-06	3.46e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—VEGFA—hypertension	4.78e-06	3.45e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CAT—hypertension	4.74e-06	3.42e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GNAS—hypertension	4.7e-06	3.39e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MMP9—hypertension	4.67e-06	3.36e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CDKN1A—hypertension	4.65e-06	3.35e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—PTEN—hypertension	4.64e-06	3.34e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—RELA—hypertension	4.63e-06	3.34e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—APOB—hypertension	4.6e-06	3.32e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—EP300—hypertension	4.57e-06	3.3e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MAPK8—hypertension	4.54e-06	3.27e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MTOR—hypertension	4.54e-06	3.27e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—AKT1—hypertension	4.52e-06	3.26e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GSTM1—hypertension	4.47e-06	3.23e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EP300—hypertension	4.42e-06	3.19e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—MYC—hypertension	4.4e-06	3.17e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—LPL—hypertension	4.39e-06	3.17e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TGFB1—hypertension	4.38e-06	3.16e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CXCL8—hypertension	4.36e-06	3.14e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—SRC—hypertension	4.3e-06	3.1e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—EGFR—hypertension	4.3e-06	3.1e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ADCY5—hypertension	4.3e-06	3.1e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—GPX1—hypertension	4.28e-06	3.09e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PRKCA—hypertension	4.24e-06	3.06e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP1A1—hypertension	4.24e-06	3.06e-05	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—AKT1—hypertension	4.21e-06	3.04e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—VEGFA—hypertension	4.19e-06	3.02e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CD36—hypertension	4.17e-06	3.01e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—IL6—hypertension	4.15e-06	2.99e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MTHFR—hypertension	3.95e-06	2.85e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MMP9—hypertension	3.94e-06	2.84e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CDKN1A—hypertension	3.93e-06	2.83e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—PTEN—hypertension	3.92e-06	2.83e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPARA—hypertension	3.88e-06	2.8e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—MYC—hypertension	3.85e-06	2.78e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TGFB1—hypertension	3.84e-06	2.77e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MAPK8—hypertension	3.83e-06	2.77e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—AKT1—hypertension	3.82e-06	2.76e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—EGFR—hypertension	3.77e-06	2.72e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—AGT—hypertension	3.76e-06	2.71e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EP300—hypertension	3.74e-06	2.7e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CALM1—hypertension	3.69e-06	2.66e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—APOE—hypertension	3.68e-06	2.65e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CAV1—hypertension	3.65e-06	2.63e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—APOA1—hypertension	3.64e-06	2.62e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—SRC—hypertension	3.64e-06	2.62e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—TP53—hypertension	3.61e-06	2.6e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—VEGFA—hypertension	3.54e-06	2.55e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—IL6—hypertension	3.3e-06	2.38e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—MYC—hypertension	3.26e-06	2.35e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TGFB1—hypertension	3.25e-06	2.34e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PPARG—hypertension	3.21e-06	2.31e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—EGFR—hypertension	3.19e-06	2.3e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—TP53—hypertension	3.17e-06	2.28e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—hypertension	3.16e-06	2.28e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—INS—hypertension	3.14e-06	2.27e-05	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—AKT1—hypertension	3.05e-06	2.2e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—IL6—hypertension	2.9e-06	2.09e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—ALB—hypertension	2.88e-06	2.08e-05	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—AKT1—hypertension	2.76e-06	1.99e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PIK3R1—hypertension	2.76e-06	1.99e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—NOS3—hypertension	2.76e-06	1.99e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—TP53—hypertension	2.68e-06	1.93e-05	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—AKT1—hypertension	2.67e-06	1.93e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTGS2—hypertension	2.52e-06	1.82e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—IL6—hypertension	2.45e-06	1.77e-05	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—AKT1—hypertension	2.26e-06	1.63e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—PTEN—hypertension	2.2e-06	1.59e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—EP300—hypertension	2.1e-06	1.51e-05	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—AKT1—hypertension	1.27e-06	9.14e-06	CbGpPWpGaD
